April 11, 2016 / 8:42 PM / a year ago

BRIEF-Valeant Pharmaceuticals enter amendment, waiver to third amended,restated agreement

April 11 (Reuters) - Valeant Pharmaceuticals International Inc

* Entered into amendment and waiver to third amended,restated credit,guaranty agreement, dated as of feb 13, 2012

* Amendment extends deadline for filing company’s form 10-k for fiscal year ended dec. 31, 2015 to may 31, 2016

* Amendment also permits company to incur up to $750 million of additional unsecured indebtedness at any time

* Amendment modifies add-backs to consolidated adjusted ebitda under credit agreement Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below